252 related articles for article (PubMed ID: 30269181)
1. Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics.
Song KH; Jung SI; Lee S; Park S; Kim ES; Park KH; Park WB; Choe PG; Kim YK; Kwak YG; Kim YS; Jang HC; Kiem S; Kim HI; Kim HB;
Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):67-74. PubMed ID: 30269181
[TBL] [Abstract][Full Text] [Related]
2. Inoculum effect of high concentrations of methicillin-susceptible Staphylococcus aureus on the efficacy of cefazolin and other beta-lactams.
Saeki M; Shinagawa M; Yakuwa Y; Nirasawa S; Sato Y; Yanagihara N; Takahashi S
J Infect Chemother; 2018 Mar; 24(3):212-215. PubMed ID: 29198902
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of a Cefazolin Inoculum Effect Associated with
Wang SK; Gilchrist A; Loukitcheva A; Plotkin BJ; Sigar IM; Gross AE; O'Donnell JN; Pettit N; Buros A; O'Driscoll T; Rhodes NJ; Bethel C; Segreti J; Charnot-Katsikas A; Singh K; Scheetz MH
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891607
[TBL] [Abstract][Full Text] [Related]
4.
Mossman AK; Svishchuk J; Waddell BJM; Izydorczyk CS; Buckley PT; Hilliard JJ; Al-Ghalith G; Zheng L; Lynch AS; Mody CH; Lisboa LF; Gregson DB; Parkins MD
Ann Am Thorac Soc; 2022 Aug; 19(8):1285-1293. PubMed ID: 35213810
[No Abstract] [Full Text] [Related]
5. Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome.
Chong YP; Park SJ; Kim ES; Bang KM; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):349-55. PubMed ID: 25213722
[TBL] [Abstract][Full Text] [Related]
6. Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.
Rincón S; Reyes J; Carvajal LP; Rojas N; Cortés F; Panesso D; Guzmán M; Zurita J; Adachi JA; Murray BE; Nannini EC; Arias CA
J Antimicrob Chemother; 2013 Dec; 68(12):2773-8. PubMed ID: 23794599
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and impact of methicillin-sensitive
Svishchuk J; Ebbert K; Waddell B; Izydorczyk C; Acosta N; Somayaji R; Rabin HR; Bjornson CL; Lisboa L; Gregson DB; Conly JM; Surette MG; Parkins MD
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0013623. PubMed ID: 37966229
[No Abstract] [Full Text] [Related]
8. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus.
Livorsi DJ; Crispell E; Satola SW; Burd EM; Jerris R; Wang YF; Farley MM
Antimicrob Agents Chemother; 2012 Aug; 56(8):4474-7. PubMed ID: 22585225
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.
Song KH; Jung SI; Lee S; Park S; Kiem SM; Lee SH; Kwak YG; Kim YK; Jang HC; Kim YS; Kim HI; Kim CJ; Park KH; Kim NJ; Oh MD; Kim HB;
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):285-294. PubMed ID: 27714592
[TBL] [Abstract][Full Text] [Related]
11. A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.
Rincon S; Carvajal LP; Gomez-Villegas SI; Echeverri AM; Rios R; Dinh A; Pedroza C; Ordoñez KM; Nannini E; Sun Z; Fowler VG; Murray BE; Miller WR; Palzkill T; Diaz L; Arias CA; Reyes J
J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33536292
[TBL] [Abstract][Full Text] [Related]
12. Novel Insights into the Classification of Staphylococcal β-Lactamases in Relation to the Cefazolin Inoculum Effect.
Carvajal LP; Rincon S; Echeverri AM; Porras J; Rios R; Ordoñez KM; Seas C; Gomez-Villegas SI; Diaz L; Arias CA; Reyes J
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071048
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
14. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.
Nannini EC; Stryjewski ME; Singh KV; Bourgogne A; Rude TH; Corey GR; Fowler VG; Murray BE
Antimicrob Agents Chemother; 2009 Aug; 53(8):3437-41. PubMed ID: 19487449
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Characterization of the Cefazolin Inoculum Effect in North American Methicillin-Susceptible Staphylococcus aureus Isolates.
Dingle TC; Gamage D; Gomez-Villegas S; Hanson BM; Reyes J; Abbott A; Burnham CD; Dien Bard J; Fritz S; Miller WR; Westblade LF; Zimmer B; Arias CA; Butler-Wu S;
J Clin Microbiol; 2022 Jul; 60(7):e0249521. PubMed ID: 35578988
[TBL] [Abstract][Full Text] [Related]
16. The cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus blood isolates: their association with dysfunctional accessory gene regulator (agr).
Wi YM; Park YK; Moon C; Ryu SY; Lee H; Ki HK; Cheong HS; Son JS; Lee JS; Kwon KT; Kim JM; Ha YE; Kang CI; Ko KS; Chung DR; Peck KR; Song JH
Diagn Microbiol Infect Dis; 2015 Nov; 83(3):286-91. PubMed ID: 26277619
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
18. The Cefazolin Inoculum Effect and the Presence of type A
Lee SO; Lee S; Park S; Lee JE; Lee SH
Infect Chemother; 2019 Dec; 51(4):376-385. PubMed ID: 31898425
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
[TBL] [Abstract][Full Text] [Related]
20. Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinations.
Bonfiglio G; Livermore DM
J Antimicrob Chemother; 1993 Sep; 32(3):431-44. PubMed ID: 8262865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
